best mid stocks january 2018 to september 2018

Tandem Diabetes Care (TNDM) had the highest return between January 1, 2018 and September 30, 2018 by a mid-cap US stock, returning 1,723%.

ASSET DATE % RETURN
Tandem Diabetes Care (TNDM)
1/1/2018 - 9/30/2018
1,722.98%
CleanSpark (CLSK)
1/1/2018 - 9/30/2018
490%
Arrowhead Pharmaceuticals (ARWR)
1/1/2018 - 9/30/2018
419.51%
Xenon Pharmaceuticals (XENE)
1/1/2018 - 9/30/2018
371.43%
Viking Therapeutics (VKTX)
1/1/2018 - 9/30/2018
325.92%
Goosehead Insurance (GSHD)
1/1/2018 - 9/30/2018
182.25%
PTC Therapeutics (PTCT)
1/1/2018 - 9/30/2018
178.77%
Novocure (NVCR)
1/1/2018 - 9/30/2018
158.77%
Vericel Corp Ord (VCEL)
1/1/2018 - 9/30/2018
154.95%
Etsy (ETSY)
1/1/2018 - 9/30/2018
150.63%
Glaukos (GKOS)
1/1/2018 - 9/30/2018
150.58%
Teladoc (TDOC)
1/1/2018 - 9/30/2018
146.36%
PAR Technology (PAR)
1/1/2018 - 9/30/2018
137.65%
Amedisys (AMED)
1/1/2018 - 9/30/2018
136.22%
United Parks & Resorts (PRKS)
1/1/2018 - 9/30/2018
131.1%
Madrigal Pharmaceuticals (MDGL)
1/1/2018 - 9/30/2018
130.77%
Skyline (SKY)
1/1/2018 - 9/30/2018
128.21%
Vicor (VICR)
1/1/2018 - 9/30/2018
118.53%
Applied Digital (APLD)
1/1/2018 - 9/30/2018
118.33%
Insperity (NSP)
1/1/2018 - 9/30/2018
106.69%
SPS Commerce (SPSC)
1/1/2018 - 9/30/2018
103.82%
Enphase Energy (ENPH)
1/1/2018 - 9/30/2018
102.93%
Addus HomeCare (ADUS)
1/1/2018 - 9/30/2018
101%
HealthEquity (HQY)
1/1/2018 - 9/30/2018
100.92%
Ligand Pharmaceuticals (LGND)
1/1/2018 - 9/30/2018
99.31%
Mid-cap stocks are treated as having a market cap between $2B and $10B.